Terms: = Liver cancer AND RBM15, Q96T37, 64783, ENSG00000162775, OTT, OTT1 AND Treatment
2 results:
1. Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation.
Yu J; Li W; Hou GJ; Sun DP; Yang Y; Yuan SX; Dai ZH; Yin HZ; Sun SH; Huang G; Zhou WP; Yang F
Exp Mol Med; 2023 Nov; 55(11):2390-2401. PubMed ID: 37907737
[TBL] [Abstract] [Full Text] [Related]
2. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy treatment Response.
Jiang H; Ning G; Wang Y; Lv W
Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
[TBL] [Abstract] [Full Text] [Related]
